Sector IntelligenceBasel

VALUATION DIAGNOSTIC
Healthcare Distribution

Specific market analysis for Healthcare Distribution companies based in Basel.

Pro-Forma Valuation

Market demand in Basel for Healthcare Distribution assets remains strong.

KEY DRIVER

"Galenica model, Swissmedic license moats, GDP compliance barriers, cold chain logistics lock-in."

Local Multiples (Est.)

5.5 - 7.5x Statutory

Get Your Report

Generate a certified valuation for your Healthcare Distribution business in Basel.

Start Valuation

Valuation Impact by Size (DACH 2025)

Size BucketMultiple RangeImpact
Micro (< CHF 1M EBITDA)3.3x - 4.4x-33.3%
Small (CHF 1M - 2M EBITDA)4.5x - 6.1x-6.7%
Transition (CHF 2M - 5M EBITDA)5.5x - 7.5x+11.1%
Lower Mid-Market (CHF 5M - 10M EBITDA)7.5x - 10.2x+33.3%
Mid-Market (> CHF 10M EBITDA)9.5x - 12.9x+66.7%

Source: NIMBO, Dealsuite, KPMG, SECA, Practitioner Interviews // Niche Baseline: 6.5x

Healthcare Distribution Market in Basel

Basel — known for a dominant pharmaceutical sector, chemical industry presence — represents a significant market for Healthcare Distribution companies in Switzerland. The local business environment is shaped by the canton's economic profile, offering distinct opportunities for both buyers and sellers in this niche.

Current EBITDA multiples for Healthcare Distribution businesses range from 5.5 - 7.5x (statutory) to 7.0 - 10.0x (deal), reflecting a moderate arbitrage opportunity. The sector trend is stable, driven by: Galenica model, Swissmedic license moats, GDP compliance barriers, cold chain logistics lock-in. This positions Basel as a notable market within the broader Distribution & Wholesale sector.

BaselEconomy Snapshot

Corporate Tax
13%
#5/26
Companies
19'800
98.8% SME
Unemployment
3.2%
Median Salary
CHF 7'600
/month
Succession Risk
28%
owners 55+

Why Healthcare Distribution in Basel?

Basel offers a diversified economic base with 19'800 total companies. While not a primary hub for Healthcare Distribution, the canton's competitive tax environment and skilled workforce create favorable conditions for business operations and valuations.

  • Global pharmaceutical capital with Novartis and Roche headquarters, creating an unrivaled life sciences ecosystem
  • Highly competitive 13.0% corporate tax rate following landmark reform, ranking 5th nationally
  • Tri-national metropolitan area with EuroAirport and direct ICE/TGV rail links to major European cities

Tax Impact on Valuation

At Basel's effective corporate tax rate of 13% (rank #5/26), after-tax EBITDA retention is 87.0%. This directly influences enterprise valuations and buyer economics in the Healthcare Distribution sector.

FAQ: Healthcare Distribution in Basel

How many Healthcare Distribution companies are in Basel?

Basel has 19'800 total companies. Specific Healthcare Distribution company counts are part of the broader industrial landscape.

What is the corporate tax rate in Basel?

The effective corporate tax rate in Basel is 13%, ranking #5 among Switzerland's 26 cantons.

What are Healthcare Distribution valuation multiples in Basel?

Current statutory EBITDA multiples for Healthcare Distribution range from 5.5 - 7.5x. Deal-based multiples are 7.0 - 10.0x. These are influenced by Basel's tax environment and local market conditions.

What is the business succession outlook in Basel?

Basel-Stadt's succession landscape is distinctive because the dominant pharma and life sciences sector is largely composed of global corporations rather than family-owned SMEs. The succession pressure is concentrated among the dense fabric of specialized service providers, suppliers, and mid-market companies that orbit the large corporates - consulting firms, logistics providers, laboratory equipment suppliers, contract manufacturers, and professional services firms. With 28% of owners over 55, the urgency is moderate but the economic value per company at risk is high. The city-canton's small size means exit pathways often involve buyers from Basel-Landschaft or Germany.

Explore all industries in Basel

Canton hub: tax data, industry composition, key employers

View Complete Healthcare Distribution National Overview →

Full Swiss market analysis across all 26 cantons, including comparable M&A transactions and sector trends.